[HTML][HTML] Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond

V Boldescu, MAM Behnam, N Vasilakis… - Nature Reviews Drug …, 2017 - nature.com
Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging
Zika virus, are an increasing and probably lasting global risk. This Review summarizes and …

Biochemistry and medicinal chemistry of the dengue virus protease

C Nitsche, S Holloway, T Schirmeister… - Chemical …, 2014 - ACS Publications
Dengue virus is the pathogenic principle behind several medical conditions. The most
common disease caused by this virus is dengue fever, characterized by high fever and flu …

Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry

T Mendgen, C Steuer, CD Klein - Journal of medicinal chemistry, 2012 - ACS Publications
Rhodanines and related five-membered heterocycles with multiple heteroatoms have
recently gained a reputation of being unselective compounds that appear as “frequent …

Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments

C Jöst, C Nitsche, T Scholz, L Roux… - Journal of medicinal …, 2014 - ACS Publications
Covalent ligand-target interactions offer significant pharmacological advantages. However,
off-target reactivity of the reactive groups, which usually have electrophilic properties, must …

Novel dengue virus NS2B/NS3 protease inhibitors

H Wu, S Bock, M Snitko, T Berger… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Dengue fever is a severe, widespread, and neglected disease with more than 2 million
diagnosed infections per year. The dengue virus NS2B/NS3 protease (PR) represents a …

Proline-based allosteric inhibitors of Zika and Dengue virus NS2B/NS3 proteases

B Millies, F von Hammerstein, A Gellert… - Journal of medicinal …, 2019 - ACS Publications
The NS2B/NS3 serine proteases of the Zika and Dengue flaviviruses are attractive targets
for the development of antiviral drugs. We report the synthesis and evaluation of a new …

Production, purification and biochemical characterization of a novel detergent-stable serine alkaline protease from Bacillus safensis strain RH12

H Rekik, NZ Jaouadi, F Gargouri, W Bejar… - International journal of …, 2019 - Elsevier
A novel extracellular protease (SAPRH) was hyper-produced (9000 U/mL) from Bacillus
safensis RH12, a newly isolated enzyme from a Tunisian offshore oil field. The enzyme was …

Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies

LRF de Sousa, H Wu, L Nebo, JB Fernandes… - Bioorganic & medicinal …, 2015 - Elsevier
Abstract NS2B-NS3 is a serine protease of the Dengue virus considered a key target in the
search for new antiviral drugs. In this study flavonoids were found to be inhibitors of NS2B …

Thiazolidinone–peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture

C Nitsche, VN Schreier, MAM Behnam… - Journal of Medicinal …, 2013 - ACS Publications
The protease of dengue virus is a promising target for antiviral drug discovery. We here
report a new generation of peptide–hybrid inhibitors of dengue protease that incorporate N …

Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue

MAM Behnam, D Graf, R Bartenschlager… - Journal of medicinal …, 2015 - ACS Publications
The dengue virus (DENV) and West Nile Virus (WNV) NS2B-NS3 proteases are attractive
targets for the development of dual-acting therapeutics against these arboviral pathogens …